ホーム › 悪性黒色腫 › カリフォルニア州

カリフォルニア州における悪性黒色腫の臨床試験

カリフォルニア州内の拠点で、悪性黒色腫に関する70件の研究が参加者を募集しています。

カリフォルニア州内の都市

公式研究テキスト（英語）

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
他20件

被験者募集中観察研究健康なボランティア歓迎

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

UCSF Medical Center at Mission Bay ( Site 4044), San Francisco

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/28更新 · NCT06961006

DESTINY-PANTUMOUR04

Research Site, San Diego

被験者募集中観察研究

18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Tower Cancer Research Foundation, Beverly Hills
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
他4件

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Providence Medical Foundation, Fullerton
Cancer and Blood Specialty Clinic, Los Alamitos
University of California Los Angeles, Los Angeles
他6件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

City of Hope, Duarte
USC Norris Comprehensive Cancer Center, Los Angeles

被験者募集中第3相

18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT05727904

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

Kaiser Permanente-Oakland, Oakland

被験者募集中第2相

25歳以下 · 全性別 · 2026/09/24更新 · NCT07621614

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379

Pan-tumor MRD Study

Los Angeles Cancer Network (LACN), Glendale
Ventura County Hematology Oncology Specialists, Oxnard
Medical Oncology Associates of San Diego (MOASD), San Diego
他2件

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/24更新 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
Mercy Cancer Center - Carmichael, Carmichael
Mercy San Juan Medical Center, Carmichael
他14件

被験者募集中第3相

75歳以上 · 全性別 · 2026/09/24更新 · NCT07068074

Intratumoral N17350 in Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles
UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
Scripps Clinic Torrey Pines - La Jolla, San Diego
他1件

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/23更新 · NCT07339176

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

City of Hope National Medical Center, Duarte

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/18更新 · NCT04752826

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0096, San Francisco

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
Epic Care-Dublin, Dublin
Bay Area Breast Surgeons Inc, Emeryville
他9件

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of California, San Diego, La Jolla
Hoag Memorial Hospital Presbyterian, Newport Beach
Redwood City, Redwood City

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

City of Hope, Duarte

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/09更新 · NCT07288112

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

University of California-San Diego, La Jolla
START Los Angeles, Los Angeles
University of California-San Fransisco, San Francisco

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/04更新 · NCT07287917

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

The Angeles Clinic, Los Angeles
UCLA, Los Angeles
University of California San Diego, Moores Cancer Center, San Diego
他1件

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/02更新 · NCT04913285

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

University of California San Francisco, San Francisco

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/02更新 · NCT07070232

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

City of Hope Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine

被験者募集中第2相

18歳以上 · 全性別 · 2026/08/31更新 · NCT05830058

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

UC San Diego Moores Cancer Center, La Jolla
Keck Medicine of USC Koreatown, Los Angeles
Los Angeles General Medical Center, Los Angeles
他1件

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/31更新 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Hospital Los Angeles, Los Angeles
Children's Hospital of Orange County, Orange
UCSF Medical Center-Mission Bay, San Francisco

被験者募集中第1/2相

12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119

Project: Every Child for Younger Patients With Cancer

Kaiser Permanente Downey Medical Center, Downey
City of Hope Comprehensive Cancer Center, Duarte
Loma Linda University Medical Center, Loma Linda
他15件

被験者募集中観察研究

25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

UC San Diego Moores Cancer Center, La Jolla
University of California, San Francisco, San Francisco

被験者募集中第2相

18歳以上 · 全性別 · 2026/08/18更新 · NCT04598009

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Community Cancer Institute, Clovis
USC/Norris Comprehensive Cancer Center, Los Angeles
Hoag Memorial Hospital Presbyterian, Newport Beach

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/17更新 · NCT04895709

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Comprehensive Blood and Cancer Center, Bakersfield
Providence Medical Foundation, Fullerton
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
他1件

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/14更新 · NCT06425926